
Align Technology, Inc.
ALGNNASDAQHealthcare● Active
$178.31
+$6.26(+3.64%)
Market Cap$12.8B
P/E Ratio—
52W High$208.31
52W Low$122
Align Technology, Inc.(ALGN)· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · ALGN · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $1.09B | $1.04B | $0.97B | $1.00B | $1.17B |
| Net Receivables | $1.16B | $1.03B | $1.05B | $1.00B | $0.99B |
| Inventory | $0.23B | $0.25B | $0.30B | $0.34B | $0.23B |
| Total Current Assets | $2.62B | $2.49B | $2.45B | $2.42B | $2.49B |
| PP&E Net | $1.24B | $1.38B | $1.41B | $1.35B | $1.20B |
| Goodwill | $0.49B | $0.44B | $0.42B | $0.41B | $0.42B |
| Intangible Assets | $0.09B | $0.10B | $0.08B | $0.10B | $0.11B |
| Total Assets | $6.23B | $6.21B | $6.08B | $5.95B | $5.94B |
| Liabilities | |||||
| Short-Term Debt | $0.03B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.12B | $0.11B | $0.11B | $0.13B | $0.16B |
| Total Current Liabilities | $1.92B | $2.04B | $2.07B | $1.93B | $1.92B |
| Long-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $2.18B | $2.36B | $2.45B | $2.35B | $2.32B |
| Stockholders Equity | |||||
| Retained Earnings | $2.46B | $2.48B | $2.45B | $2.57B | $2.62B |
| Total Stockholders Equity | $4.05B | $3.85B | $3.63B | $3.60B | $3.62B |
| Total Liab & Equity(computed) | $6.23B | $6.21B | $6.08B | $5.95B | $5.94B |
| Debt Summary | |||||
| Total Debt | $0.11B | $0.12B | $0.13B | $0.13B | $0.13B |
| Net Debt | ($0.96B) | ($0.92B) | ($0.81B) | ($0.82B) | ($0.97B) |
数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · B
深入了解Align Technology, Inc.
关于Align Technology, Inc.(ALGN)资产负债表
Align Technology, Inc.总资产$6.23B,现金及短期投资$1.09B,总负债$2.18B,总债务$0.11B,股东权益$4.05B。
常见问题
ALGN · 4 问Align Technology, Inc.总债务$0.11B,净债务($0.96B)。
ALGN total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10